CELEX: 62021TA0149
Language: en
Date: 2022-03-02 00:00:00
Title: Case T-149/21: Judgment of the General Court of 2 March 2022 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark VITADHA — Earlier Spanish word mark VITANADH — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

25.4.2022   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 171/31
            
         
      Judgment of the General Court of 2 March 2022 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA)
      (Case T-149/21) (1)
      
      (EU trade mark - Opposition proceedings - International registration designating the European Union - Word mark VITADHA - Earlier Spanish word mark VITANADH - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))
      (2022/C 171/40)
      Language of the case: English
      
         Parties
      
      
         Applicant: UGA Nutraceuticals Srl (Gubbio, Italy) (represented by: M. Riva, J. Graffer and A. Ottolini, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral, acting as Agent)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Vitae Health Innovation, SL (Montmeló, Spain) (represented by: E. Torner Lasalle, lawyer)
      
         Re:
      
      Action brought against the decision of the Fourth Board of Appeal of EUIPO of 15 January 2021 (Case R 2719/2019-4), relating to opposition proceedings between Vitae Health Innovation and UGA Nutraceuticals.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders UGA Nutraceuticals Srl to pay the costs.
               
            
         (1)  OJ C 182, 10.5.2021.